Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement

被引：36
作者：
Marson, P. [1 ]
Bagatella, P. [1 ]
Bortolati, M. [2 ]
Tison, T. [1 ]
De Silvestro, G. [1 ]
Fabris, F. [3 ]
Pengo, V. [4 ]
Ruffatti, A. [2 ]
机构：
[1] Univ Hosp Padua, Apheresis Unit, Blood Transfus Serv, I-35128 Padua, Italy
[2] Univ Padua, Sch Med, Rheumatol Unit, Dept Clin & Expt Med, Padua, Italy
[3] Univ Padua, Sch Med, Dept Med & Surg Sci, Padua, Italy
[4] Univ Padua, Thrombosis Ctr, Padua, Italy
来源：
JOURNAL OF INTERNAL MEDICINE | 2008年 / 264卷 / 02期
关键词：
D O I：
10.1111/j.1365-2796.2008.01942.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：201 / 203
页数：3
相关论文
共 17 条
[1]   Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome [J].
Amoura, Z ;
Costedoat-Chalumeau, N ;
Veyradier, AS ;
Wolf, M ;
Ghillani-Dalbin, P ;
Cacoub, P ;
Meyer, D ;
Piette, JC .
ARTHRITIS AND RHEUMATISM, 2004, 50 (10) :3260-3264
[2]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[3]   New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS") [J].
Asherson, Ronald A. .
AUTOIMMUNITY REVIEWS, 2006, 6 (02) :76-80
[4]   Mortality in the catastrophic antiphospholipid syndrome:: Causes of death and prognostic factors [J].
Bucciarelli, Silvia ;
Cervera, Ricard ;
Espinosa, Gerard ;
Gomez-Puerta, Jose A. ;
Ramos-Casals, Manuel ;
Font, Josep .
AUTOIMMUNITY REVIEWS, 2006, 6 (02) :72-75
[5]   Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome [J].
Erkan, Doruk .
AUTOIMMUNITY REVIEWS, 2006, 6 (02) :98-103
[6]   Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies [J].
Espinosa, G ;
Bucciarelli, S ;
Cervera, R ;
Lozano, M ;
Reverter, JC ;
de la Red, G ;
Gil, V ;
Ingelmo, M ;
Font, J ;
Asherson, RA .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (06) :730-736
[7]   Treatment of thrombotic thrombocytopenic purpura [J].
Fontana, S ;
Hovinga, JAK ;
Lämmle, B ;
Taleghani, BM .
VOX SANGUINIS, 2006, 90 (04) :245-254
[8]   The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP) [J].
Hovinga, JAK ;
Studt, JD ;
Lämmle, B .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) :417-421
[9]   Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome [J].
Koenig, M ;
Roy, M ;
Baccot, S ;
Cuilleron, M ;
de Filippis, JP ;
Cathébrasl, P .
CLINICAL RHEUMATOLOGY, 2005, 24 (02) :166-168
[10]   Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation [J].
Miesbach, W ;
Scharrer, I ;
Asherson, RA .
CLINICAL RHEUMATOLOGY, 2004, 23 (03) :256-261
12